Subscribe
Be the first with the news that moves the market- AgraFlora Organics’ (CSE:AGRA) subsidiary, The Edibles and Infusion Corporation, has completed its edibles manufacturing facility
- The company will now apply for a Standard Processing license from Health Canada
- The Edibles and Infusion Corporation expects to produce over 250,000 units of edibles per eight-hour shift
- First revenue generation is expected to begin in the fourth quarter of this year
- AgraFlora Organics (AGRA) is currently up 10 per cent, with shares trading at 5.5 cents and a market cap of C$46.81 million
AgraFlora Organics’ (CSE:AGRA) subsidiary, The Edibles and Infusion Corporation (EIC), has completed its edibles manufacturing facility.
Located in Winnipeg, Manitoba, the 51,000 square foot, fully automated facility has been designed to exceed regulatory standards regarding security, cleanliness and product safety.
As such, the state-of-the-art equipment will enable the company to pursue EU-GMP certification in the future.
The specialised equipment will allow EIC to accurately dosed products while also mitigating the risk of contamination or degradation of the raw cannabis inputs. EIC now plans to apply for a Standard Processing License from Health Canada, which it expects will be submitted before the end of May this year.
Operating at full capacity, the facility is anticipated to produce more than 250,000 units per eight-hour shift. It also has the ability to operate 24 hours a day and requires only 30 staff to maintain peak production levels due to the implementation of automated processes.
In addition, the facility has been designed to accommodate for product diversification outside of the company’s gummy range, including chocolates and drinks.
Brandon Boddy, Chairman and CEO of AgraFlora Organics, said the company aims to become a leader in the production of cannabis-infused gummies, which it considers to be the most attractive cannabis 2.0 product category.
“To date, the gummy category has not been fully supplied as companies have struggled to scale up manufacturing,” he said.
“We chose EIC’s management team based on their experience and our expectation of being able to scale quickly post-license to meet the needs of Canadian consumers and brands,” he said.
EIC currently holds a Research and Development License, issued by Health Canada, which allows it to produce cannabis edibles for the purpose of recipe development.
The company plans to use this license to perfect its recipes with white-label clients, thereby establishing commercial relationships in readiness for full-scale production.
AgraFlora Organics (AGRA) is currently up 10 per cent, with shares trading for 5.5 cents at 12:17pm EDT.
